UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 620

Sortiert nach

Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies

Journal of clinical oncology, 2013-03, Vol.31 (8), p.1039-1049

2013

Link zum Volltext

Verfügbarkeit prüfen

The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

Clinical cancer research, 2018-08, Vol.24 (15), p.3528-3538

2018

Link zum Volltext

Verfügbarkeit prüfen

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.1560-1568

2018

Link zum Volltext

Verfügbarkeit prüfen

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases

Cancer, 2020-07, Vol.126 (14), p.3219-3228

2020

Link zum Volltext

Verfügbarkeit prüfen

KRAS G12C-Mutant Non-Small Cell Lung Cancer: Biology, Developmental Therapeutics, and Molecular Testing

The Journal of molecular diagnostics : JMD, 2021-05, Vol.23 (5), p.507-520

2021

Link zum Volltext

Verfügbarkeit prüfen

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1248-1268

2018

Link zum Volltext

Verfügbarkeit prüfen

The evolving role of liquid biopsy in lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-10, Vol.172, p.53-64

2022

Link zum Volltext

Verfügbarkeit prüfen

Aurora Kinases as Anticancer Drug Targets

Clinical cancer research, 2008-03, Vol.14 (6), p.1639-1648

2008

Link zum Volltext

Verfügbarkeit prüfen

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.946-963

2016

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions

Molecular cancer therapeutics, 2018-05, Vol.17 (5), p.885-896

2018

Link zum Volltext

Verfügbarkeit prüfen

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer

Nature medicine, 2015-09, Vol.21 (9), p.1038-1047

2015

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation

Journal of thoracic oncology, 2022-02, Vol.17 (2), p.214-227

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2018-05, Vol.319 (18), p.1880

2018

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific Neutralization

Journal of clinical oncology, 2022-11, Vol.40 (33), p.3787-3789

2022

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2014-04, Vol.32 (11), p.1136-1142

2014

Link zum Volltext

Verfügbarkeit prüfen

SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway–Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.1847-1852

2019

Link zum Volltext

Verfügbarkeit prüfen

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Journal of experimental & clinical cancer research, 2022-06, Vol.41 (1), p.186-186, Article 186

2022

Link zum Volltext

Verfügbarkeit prüfen

A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

BMC cancer, 2021-04, Vol.21 (1), p.441-441, Article 441

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)

Clinical cancer research, 2022-09, Vol.28 (17), p.3752-3760

2022

Link zum Volltext

Verfügbarkeit prüfen

Ethnic difference in lung cancer: an important issue in a globalized society

Journal of thoracic disease, 2020-07, Vol.12 (7), p.3774-3775

2020

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

The lancet oncology, 2018-01, Vol.19 (1), p.101-114

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma

The oncologist (Dayton, Ohio), 2022-06, Vol.27 (6), p.476-486

2022

Link zum Volltext

Verfügbarkeit prüfen

Plasma-Based Tumor Genetics for Monitoring Disease Progression: What Can We Learn from a Tube of Blood?

Journal of thoracic oncology, 2015-04, Vol.10 (4), p.546-547

Mack, Philip C.

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 620

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(581)
Mit Volltextzugriff
(553)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(338)
Life Sciences & Biomedicine
(319)
Humans
(282)
Male
(162)
Female
(142)
Oncology
(133)
Middle Aged
(95)
Biological And Medical Sciences
(93)
Aged
(87)
Medical Sciences
(84)
Adult
(70)
Lung Neoplasms - Drug Therapy
(68)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(53)
Aged, 80 And Over
(49)
Treatment Outcome
(48)
Lung Neoplasms - Pathology
(46)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(41)
Animals
(36)
Carcinoma, Non-Small-Cell Lung - Pathology
(36)
Social Sciences
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies

The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases

KRAS G12C-Mutant Non-Small Cell Lung Cancer: Biology, Developmental Therapeutics, and Molecular Testing

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

The evolving role of liquid biopsy in lung cancer

Aurora Kinases as Anticancer Drug Targets

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer

Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial

Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific Neutralization

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway–Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)

Ethnic difference in lung cancer: an important issue in a globalized society

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma

Plasma-Based Tumor Genetics for Monitoring Disease Progression: What Can We Learn from a Tube of Blood?

Suchergebnisse filtern